Center For Sight - Medicare Optometrist in Natchitoches, LA

Center For Sight is a medicare enrolled "Optometrist" provider in Natchitoches, Louisiana. Their current practice location is 140 E 5th St, Natchitoches, Louisiana. You can reach out to their office (for appointments etc.) via phone at (318) 357-8194.

Center For Sight is licensed to practice in Louisiana (license number 1419543T) and it also participates in the medicare program. Center For Sight is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1508943374.

Contact Information

Center For Sight
140 E 5th St,
Natchitoches, LA 71457-5725
(318) 357-8194
(318) 352-3145



Healthcare Provider's Profile

Full NameCenter For Sight
TypeFacility
SpecialityOptometrist
Location140 E 5th St, Natchitoches, Louisiana
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1508943374
  • Provider Enumeration Date: 11/01/2006
  • Last Update Date: 03/13/2008
  Medicare PECOS Information:
  • PECOS PAC ID: 0042312258
  • Enrollment ID: O20070219000406

Medical Identifiers

Medical identifiers for Center For Sight such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1508943374NPI-NPPES
5862720001OtherLASUPPLIER (DME)
1407895MedicaidLA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist 1419543T (Louisiana)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Center For Sight acts as a billing entity for following providers:
Provider NamePete Wardell
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1467495382
PECOS PAC ID: 8527093111
Enrollment ID: I20051003000489

News Archive

Study implicates protein as a trigger of advanced prostate cancer recurrence

Scientists with the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have for the first time implicated a growth-promoting cellular protein as one trigger of the inevitable recurrence of advanced prostate cancer in men who are undergoing drug treatment to shut down their sex hormones, or androgens.

Psychedelics and their role in treatment of mental health disorders

Psychedelics such as LSD, magic mushrooms, mescaline etc. have garnered renewed interest in the scientific world because of the possible role they could play in mental health problems. Ketamine remains the only hallucinogen at present that is used clinically as an anesthetic agent. The others are all classified under banned drugs.

Dynatronics third-quarter fiscal 2010 sales increase 7.9% to $8,235,060

Dynatronics Corporation today announced results for its fiscal third quarter ended March 31, 2010. Sales for the quarter increased 7.9 percent to $8,235,060, compared to $7,633,419 for the third quarter of the prior fiscal year. For the nine-month period ended March 31, 2010, sales increased 2.8 percent to $25,018,960, compared to $24,348,461 for the same period in the prior fiscal year.

Study finds racial disparities among adolescents in receiving treatment for depression

Adolescence can herald the onset of major depression and the associated short- and long-term consequences including developmental and social impairment. Research that focuses on access to treatment for adolescents with depression can shine a bright light on the persistent disparities based on race and ethnicity.

Read more Medical News

› Verified 3 days ago

Provider NameRandall D Keator
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1124171798
PECOS PAC ID: 6507945524
Enrollment ID: I20080502000025

News Archive

Study implicates protein as a trigger of advanced prostate cancer recurrence

Scientists with the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have for the first time implicated a growth-promoting cellular protein as one trigger of the inevitable recurrence of advanced prostate cancer in men who are undergoing drug treatment to shut down their sex hormones, or androgens.

Psychedelics and their role in treatment of mental health disorders

Psychedelics such as LSD, magic mushrooms, mescaline etc. have garnered renewed interest in the scientific world because of the possible role they could play in mental health problems. Ketamine remains the only hallucinogen at present that is used clinically as an anesthetic agent. The others are all classified under banned drugs.

Dynatronics third-quarter fiscal 2010 sales increase 7.9% to $8,235,060

Dynatronics Corporation today announced results for its fiscal third quarter ended March 31, 2010. Sales for the quarter increased 7.9 percent to $8,235,060, compared to $7,633,419 for the third quarter of the prior fiscal year. For the nine-month period ended March 31, 2010, sales increased 2.8 percent to $25,018,960, compared to $24,348,461 for the same period in the prior fiscal year.

Study finds racial disparities among adolescents in receiving treatment for depression

Adolescence can herald the onset of major depression and the associated short- and long-term consequences including developmental and social impairment. Research that focuses on access to treatment for adolescents with depression can shine a bright light on the persistent disparities based on race and ethnicity.

Read more Medical News

› Verified 3 days ago

Provider NameWyche Coleman
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1841491826
PECOS PAC ID: 0941473359
Enrollment ID: I20111031000704

News Archive

Study implicates protein as a trigger of advanced prostate cancer recurrence

Scientists with the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have for the first time implicated a growth-promoting cellular protein as one trigger of the inevitable recurrence of advanced prostate cancer in men who are undergoing drug treatment to shut down their sex hormones, or androgens.

Psychedelics and their role in treatment of mental health disorders

Psychedelics such as LSD, magic mushrooms, mescaline etc. have garnered renewed interest in the scientific world because of the possible role they could play in mental health problems. Ketamine remains the only hallucinogen at present that is used clinically as an anesthetic agent. The others are all classified under banned drugs.

Dynatronics third-quarter fiscal 2010 sales increase 7.9% to $8,235,060

Dynatronics Corporation today announced results for its fiscal third quarter ended March 31, 2010. Sales for the quarter increased 7.9 percent to $8,235,060, compared to $7,633,419 for the third quarter of the prior fiscal year. For the nine-month period ended March 31, 2010, sales increased 2.8 percent to $25,018,960, compared to $24,348,461 for the same period in the prior fiscal year.

Study finds racial disparities among adolescents in receiving treatment for depression

Adolescence can herald the onset of major depression and the associated short- and long-term consequences including developmental and social impairment. Research that focuses on access to treatment for adolescents with depression can shine a bright light on the persistent disparities based on race and ethnicity.

Read more Medical News

› Verified 3 days ago

Provider NameLawrence Pham
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1730444704
PECOS PAC ID: 0345498069
Enrollment ID: I20120920000658

News Archive

Study implicates protein as a trigger of advanced prostate cancer recurrence

Scientists with the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have for the first time implicated a growth-promoting cellular protein as one trigger of the inevitable recurrence of advanced prostate cancer in men who are undergoing drug treatment to shut down their sex hormones, or androgens.

Psychedelics and their role in treatment of mental health disorders

Psychedelics such as LSD, magic mushrooms, mescaline etc. have garnered renewed interest in the scientific world because of the possible role they could play in mental health problems. Ketamine remains the only hallucinogen at present that is used clinically as an anesthetic agent. The others are all classified under banned drugs.

Dynatronics third-quarter fiscal 2010 sales increase 7.9% to $8,235,060

Dynatronics Corporation today announced results for its fiscal third quarter ended March 31, 2010. Sales for the quarter increased 7.9 percent to $8,235,060, compared to $7,633,419 for the third quarter of the prior fiscal year. For the nine-month period ended March 31, 2010, sales increased 2.8 percent to $25,018,960, compared to $24,348,461 for the same period in the prior fiscal year.

Study finds racial disparities among adolescents in receiving treatment for depression

Adolescence can herald the onset of major depression and the associated short- and long-term consequences including developmental and social impairment. Research that focuses on access to treatment for adolescents with depression can shine a bright light on the persistent disparities based on race and ethnicity.

Read more Medical News

› Verified 3 days ago

Provider NameTiffany M Griffin
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1730468851
PECOS PAC ID: 4486816709
Enrollment ID: I20140507001362

News Archive

Study implicates protein as a trigger of advanced prostate cancer recurrence

Scientists with the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have for the first time implicated a growth-promoting cellular protein as one trigger of the inevitable recurrence of advanced prostate cancer in men who are undergoing drug treatment to shut down their sex hormones, or androgens.

Psychedelics and their role in treatment of mental health disorders

Psychedelics such as LSD, magic mushrooms, mescaline etc. have garnered renewed interest in the scientific world because of the possible role they could play in mental health problems. Ketamine remains the only hallucinogen at present that is used clinically as an anesthetic agent. The others are all classified under banned drugs.

Dynatronics third-quarter fiscal 2010 sales increase 7.9% to $8,235,060

Dynatronics Corporation today announced results for its fiscal third quarter ended March 31, 2010. Sales for the quarter increased 7.9 percent to $8,235,060, compared to $7,633,419 for the third quarter of the prior fiscal year. For the nine-month period ended March 31, 2010, sales increased 2.8 percent to $25,018,960, compared to $24,348,461 for the same period in the prior fiscal year.

Study finds racial disparities among adolescents in receiving treatment for depression

Adolescence can herald the onset of major depression and the associated short- and long-term consequences including developmental and social impairment. Research that focuses on access to treatment for adolescents with depression can shine a bright light on the persistent disparities based on race and ethnicity.

Read more Medical News

› Verified 3 days ago

Provider NameBrehana Hawkins
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1396224721
PECOS PAC ID: 6709139207
Enrollment ID: I20181031000970

News Archive

Study implicates protein as a trigger of advanced prostate cancer recurrence

Scientists with the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have for the first time implicated a growth-promoting cellular protein as one trigger of the inevitable recurrence of advanced prostate cancer in men who are undergoing drug treatment to shut down their sex hormones, or androgens.

Psychedelics and their role in treatment of mental health disorders

Psychedelics such as LSD, magic mushrooms, mescaline etc. have garnered renewed interest in the scientific world because of the possible role they could play in mental health problems. Ketamine remains the only hallucinogen at present that is used clinically as an anesthetic agent. The others are all classified under banned drugs.

Dynatronics third-quarter fiscal 2010 sales increase 7.9% to $8,235,060

Dynatronics Corporation today announced results for its fiscal third quarter ended March 31, 2010. Sales for the quarter increased 7.9 percent to $8,235,060, compared to $7,633,419 for the third quarter of the prior fiscal year. For the nine-month period ended March 31, 2010, sales increased 2.8 percent to $25,018,960, compared to $24,348,461 for the same period in the prior fiscal year.

Study finds racial disparities among adolescents in receiving treatment for depression

Adolescence can herald the onset of major depression and the associated short- and long-term consequences including developmental and social impairment. Research that focuses on access to treatment for adolescents with depression can shine a bright light on the persistent disparities based on race and ethnicity.

Read more Medical News

› Verified 3 days ago

Provider NameIdell Marie Mitchell
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1306406269
PECOS PAC ID: 3072931500
Enrollment ID: I20200916000633

News Archive

Study implicates protein as a trigger of advanced prostate cancer recurrence

Scientists with the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have for the first time implicated a growth-promoting cellular protein as one trigger of the inevitable recurrence of advanced prostate cancer in men who are undergoing drug treatment to shut down their sex hormones, or androgens.

Psychedelics and their role in treatment of mental health disorders

Psychedelics such as LSD, magic mushrooms, mescaline etc. have garnered renewed interest in the scientific world because of the possible role they could play in mental health problems. Ketamine remains the only hallucinogen at present that is used clinically as an anesthetic agent. The others are all classified under banned drugs.

Dynatronics third-quarter fiscal 2010 sales increase 7.9% to $8,235,060

Dynatronics Corporation today announced results for its fiscal third quarter ended March 31, 2010. Sales for the quarter increased 7.9 percent to $8,235,060, compared to $7,633,419 for the third quarter of the prior fiscal year. For the nine-month period ended March 31, 2010, sales increased 2.8 percent to $25,018,960, compared to $24,348,461 for the same period in the prior fiscal year.

Study finds racial disparities among adolescents in receiving treatment for depression

Adolescence can herald the onset of major depression and the associated short- and long-term consequences including developmental and social impairment. Research that focuses on access to treatment for adolescents with depression can shine a bright light on the persistent disparities based on race and ethnicity.

Read more Medical News

› Verified 3 days ago

Provider NameKaren Evelyn Ezelle
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1558978700
PECOS PAC ID: 5193144384
Enrollment ID: I20201008000980

News Archive

Study implicates protein as a trigger of advanced prostate cancer recurrence

Scientists with the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have for the first time implicated a growth-promoting cellular protein as one trigger of the inevitable recurrence of advanced prostate cancer in men who are undergoing drug treatment to shut down their sex hormones, or androgens.

Psychedelics and their role in treatment of mental health disorders

Psychedelics such as LSD, magic mushrooms, mescaline etc. have garnered renewed interest in the scientific world because of the possible role they could play in mental health problems. Ketamine remains the only hallucinogen at present that is used clinically as an anesthetic agent. The others are all classified under banned drugs.

Dynatronics third-quarter fiscal 2010 sales increase 7.9% to $8,235,060

Dynatronics Corporation today announced results for its fiscal third quarter ended March 31, 2010. Sales for the quarter increased 7.9 percent to $8,235,060, compared to $7,633,419 for the third quarter of the prior fiscal year. For the nine-month period ended March 31, 2010, sales increased 2.8 percent to $25,018,960, compared to $24,348,461 for the same period in the prior fiscal year.

Study finds racial disparities among adolescents in receiving treatment for depression

Adolescence can herald the onset of major depression and the associated short- and long-term consequences including developmental and social impairment. Research that focuses on access to treatment for adolescents with depression can shine a bright light on the persistent disparities based on race and ethnicity.

Read more Medical News

› Verified 3 days ago

Provider NameLynsey Rita Eveland
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1689050437
PECOS PAC ID: 7113227562
Enrollment ID: I20211011003215

News Archive

Study implicates protein as a trigger of advanced prostate cancer recurrence

Scientists with the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have for the first time implicated a growth-promoting cellular protein as one trigger of the inevitable recurrence of advanced prostate cancer in men who are undergoing drug treatment to shut down their sex hormones, or androgens.

Psychedelics and their role in treatment of mental health disorders

Psychedelics such as LSD, magic mushrooms, mescaline etc. have garnered renewed interest in the scientific world because of the possible role they could play in mental health problems. Ketamine remains the only hallucinogen at present that is used clinically as an anesthetic agent. The others are all classified under banned drugs.

Dynatronics third-quarter fiscal 2010 sales increase 7.9% to $8,235,060

Dynatronics Corporation today announced results for its fiscal third quarter ended March 31, 2010. Sales for the quarter increased 7.9 percent to $8,235,060, compared to $7,633,419 for the third quarter of the prior fiscal year. For the nine-month period ended March 31, 2010, sales increased 2.8 percent to $25,018,960, compared to $24,348,461 for the same period in the prior fiscal year.

Study finds racial disparities among adolescents in receiving treatment for depression

Adolescence can herald the onset of major depression and the associated short- and long-term consequences including developmental and social impairment. Research that focuses on access to treatment for adolescents with depression can shine a bright light on the persistent disparities based on race and ethnicity.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Center For Sight is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Center For Sight
140 E 5th St,
Natchitoches, LA 71457-5725

Ph: (318) 357-8194
Center For Sight
140 E 5th St,
Natchitoches, LA 71457-5725

Ph: (318) 357-8194

News Archive

Study implicates protein as a trigger of advanced prostate cancer recurrence

Scientists with the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have for the first time implicated a growth-promoting cellular protein as one trigger of the inevitable recurrence of advanced prostate cancer in men who are undergoing drug treatment to shut down their sex hormones, or androgens.

Psychedelics and their role in treatment of mental health disorders

Psychedelics such as LSD, magic mushrooms, mescaline etc. have garnered renewed interest in the scientific world because of the possible role they could play in mental health problems. Ketamine remains the only hallucinogen at present that is used clinically as an anesthetic agent. The others are all classified under banned drugs.

Dynatronics third-quarter fiscal 2010 sales increase 7.9% to $8,235,060

Dynatronics Corporation today announced results for its fiscal third quarter ended March 31, 2010. Sales for the quarter increased 7.9 percent to $8,235,060, compared to $7,633,419 for the third quarter of the prior fiscal year. For the nine-month period ended March 31, 2010, sales increased 2.8 percent to $25,018,960, compared to $24,348,461 for the same period in the prior fiscal year.

Study finds racial disparities among adolescents in receiving treatment for depression

Adolescence can herald the onset of major depression and the associated short- and long-term consequences including developmental and social impairment. Research that focuses on access to treatment for adolescents with depression can shine a bright light on the persistent disparities based on race and ethnicity.

Read more News

› Verified 3 days ago


Optometrist in Natchitoches, LA

Dr. Randall Denison Keator Ii, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 140 E 5th St, Natchitoches, LA 71457
Phone: 318-357-8194    Fax: 318-352-3145
Randall Keator, Ii, O.d., Llc
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 140 E 5th St, Natchitoches, LA 71457
Phone: 318-357-8194    Fax: 318-352-3145
Dr. Pete Wardell, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 946 Keyser Ave, Natchitoches, LA 71457
Phone: 318-357-8194    Fax: 318-357-3145
Dr. Cheryl Turyn Stoker, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 118 South Dr, Natchitoches, LA 71457
Phone: 318-352-0444    Fax: 318-352-6860
Karen Evelyn Ezelle, DO
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 946 Keyser Ave, Natchitoches, LA 71457
Phone: 318-357-8194    Fax: 318-352-3145
Pete Wardell O.d. Llc
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 104 Chinquapin Cir, Natchitoches, LA 71457
Phone: 318-332-6171    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.